At Tethis we aim to make liquid biopsy a standard, reproducible, oncology diagnostic. Our proprietary slides allow immediate, fully automated and gentle processing of blood samples, three unaddressed elements that are crucial to ensure standardization and to maintain clinical informativity. High throughput analytical protocols are then performed for highly sensitive and specific blood-based cancer testing in different clinical settings.
Location: Italy, Lombardy, Milan
Employees: 11-50
Total raised: $15.4M
Investors 1
| Date | Name | Website |
| - | Indaco Ven... | indacosgr.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.01.2025 | - | $15.4M | - |
Mentions in press and media 4
| Date | Title | Description |
| 11.04.2025 | Italy's Tech Renaissance: A Surge Amid Global Challenges | Italy is on the rise. The tech sector is thriving, defying global economic headwinds. In the first quarter of 2025, Italy raised over $315 million. This figure mirrors last year’s performance, signaling resilience. The enterprise value of t... |
| 11.04.2025 | Italy defies global slowdown with $315M raised in Q1 and Jeff Bezos to headline Italian Tech Week | Following a sustained effort to drive innovation across the country, Italy’s tech sector continues to expand by raising more than $315 million in Q1 2025 and hitting an enterprise value of $82 billion. Despite global slowdowns, Italy’s earl... |
| 14.01.2025 | Tethis Raises €15M in Funding | Tethis, a Milan, Italy-based cancer diagnostics company, raised €15M in Funding. The round was led by Enea TECH and Biomedical Foundation. The company intends to use the funds to accelerate the development, validation and preparation for co... |
| 06.07.2010 | Tethis Receives Investment from Atlante Ventures | Tethis s.r.l., a Milan, Italy-based company committed to developing novel nanostructured thin layers to apply to innovative tools for environmental monitoring, diagnostics and drug discovery, has received a €3m investment from Atlante Ventu... |